Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Verrill

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|October 4, 2017
IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancerTamara Aleksic, Clare Verrill, Richard J Bryant, et al.
JAMA Oncology|October 16, 2025
Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical TrialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 21, 2021
Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsiesAndrea Chatrian, Richard T Colling, Lisa Browning, et al.
Cold Spring Harbor Molecular Case Studies|May 11, 2017
Whole-genome sequencing identifies homozygous <i>BRCA2</i> deletion guiding treatment in dedifferentiated prostate cancerKarin Purshouse, Anna Schuh, Benjamin P Fairfax, et al.
Cancer Research|November 20, 2018
An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal CellsJoshua D Freedman, Margaret R Duffy, Janet Lei-Rossmann, et al.
European Journal of Immunology|October 30, 2020
IFITM3-specific antibody reveals IFN preferences and slow IFN induction of the antiviral factor IFITM3 in humansDannielle Wellington, Zixi Yin, Adi Abdel-Haq, et al.
Cancer Immunology Research|June 20, 2019
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8<sup>+</sup> Tumor-Infiltrating T Lymphocyte ResponsesMegat Abd Hamid, Ruo-Zheng Wang, Xuan Yao, et al.
Cancer Immunology Research|November 28, 2019
Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector ResponsesMegat Abd Hamid, Huw Colin-York, Nasullah Khalid-Alham, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
Cancer Research|May 9, 2018
Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor StageTamara Aleksic, Nicki Gray, Xiaoning Wu, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|October 4, 2017
IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancerTamara Aleksic, Clare Verrill, Richard J Bryant, et al.
JAMA Oncology|October 16, 2025
Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical TrialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 21, 2021
Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsiesAndrea Chatrian, Richard T Colling, Lisa Browning, et al.
Cold Spring Harbor Molecular Case Studies|May 11, 2017
Whole-genome sequencing identifies homozygous <i>BRCA2</i> deletion guiding treatment in dedifferentiated prostate cancerKarin Purshouse, Anna Schuh, Benjamin P Fairfax, et al.
Cancer Research|November 20, 2018
An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal CellsJoshua D Freedman, Margaret R Duffy, Janet Lei-Rossmann, et al.
European Journal of Immunology|October 30, 2020
IFITM3-specific antibody reveals IFN preferences and slow IFN induction of the antiviral factor IFITM3 in humansDannielle Wellington, Zixi Yin, Adi Abdel-Haq, et al.
Cancer Immunology Research|June 20, 2019
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8<sup>+</sup> Tumor-Infiltrating T Lymphocyte ResponsesMegat Abd Hamid, Ruo-Zheng Wang, Xuan Yao, et al.
Cancer Immunology Research|November 28, 2019
Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector ResponsesMegat Abd Hamid, Huw Colin-York, Nasullah Khalid-Alham, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
Cancer Research|May 9, 2018
Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor StageTamara Aleksic, Nicki Gray, Xiaoning Wu, et al.
Pageof 11